Dariohealth expands glp-1 weight-loss solution, unlocking new revenue streams in rapidly growing multi billion dollar market

New york--(business wire)--market news alerts updates that dariohealth corp. (nasdaq: drio) is taking another bold step into the rapidly growing weight-loss market, now projected to exceed $100 billion annually by 2030. the company's latest move expands its glp-1 offering with prescribing capabilities, positioning dario to capture a larger share of this lucrative space as demand for medical weight-loss solutions skyrockets across employers and consumers. following the announcement, dario's shar.
DRIO Ratings Summary
DRIO Quant Ranking